• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】15512

【品名】Glutaric Anhydride; dihydro-2H-pyran-2,6(3H)-dione

【CA登记号】108-55-4

【 分 子 式 】C5H6O3

【 分 子 量 】114.10084

【元素组成】C 52.63% H 5.3% O 42.07%

与该中间体有关的原料药合成路线共 8 条

合成路线1

该中间体在本合成路线中的序号:(II)

A new synthesis of FK-1052 has been performed by two closely related ways: 1) The reaction of 2-methylaniline (I) with glutaric anhydride (II) gives the corresponding glutarimide (III), which is brominated with N-bromosuccinimide (NBS) and benzoyl peroxide in CCl4 to the bromomethyl derivative (IV). The reaction of (IV) with triphenylphosphine yields the phosphonium bromide (V), which, by an intramolecular Wittig reaction with 1,8 diazabicyclo[5.4.0]undec-7-ene (DBU) in DMF affords 6,7,8,9-tetrahydropyrido[1,2-a]indol-6-one (VI). The condensation of (VI) with 5-methyl-1-(triphenylmethyl)imidazole-4-carbaldehyde (VII) by means of lithium diisopropylamide (LDA) in THF gives the condensed methanol derivative (VIII), which is acetylated with acetic anhydride and pyridine to the acetoxy compound (IX), and converted into the olefine (X) by reaction with DBU in toluene. Elimination of the triphenylmethyl group of (X) with aqueous acetic acid gives 7-(5-methyl-1H-imidazol-4-ylmethylene)-6,7,8,9-tetrahydropyrido[1,2-a]indol-6-one (XI), which is hydrogenated over Pd/C and ammonium formate in THF/water to afford the saturated compound (XII). Optical resolution of (XII) with di-p-toluyl-D-tartaric acid as usual, gives the (+)-enantiomer (XIII), which is treated with paraformaldehyde and dimethylamine in aqueous acetic acid to yield the (+)-dimethylaminomethyl compound (XIV). Finally, the dimethylamino group is eliminated with Pd/C and ammonium formate in THF/ethanol/water. 2) The final steps of the preceding sequence can also be performed in reverse order: The racemic compound (XII) is first treated with paraformaldehyde and dimethylamine as before to give the racemic dimethylaminomethyl compound (XVI), which is deaminated with Pd/C and ammonium formate as before to the racemic FK-1052 (XVI). Finally, this compound is submitted to optical resolution with di-p-toluyl-D-tartaric acid as before.

1 Takasugi, H.; Ito, K.; Kato, M.; Nishino, S.; New 5-HT3 (serotonin-3) receptor antagonists. III. An efficient synthesis of carbon 14-labeled (+)-8,9-dihydro-10-methyl-7-[(5-methyl-1H-imidazol-4-yl)methyl]pyrido[1,2-a]indol-6(7H)-one hydrochloride (FK 1052). Chem Pharm Bull 1995, 43, 8, 1346.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 15511 o-toluidine; 2-methylphenylamine;2-Methylaniline;2-Aminotoluene;1-Amino-2-methylbenzene;1-Methyl-2-aminobenzene; ortho-Toluidine 95-53-4 C7H9N 详情 详情
(II) 15512 Glutaric Anhydride; dihydro-2H-pyran-2,6(3H)-dione 108-55-4 C5H6O3 详情 详情
(III) 15513 1-(2-methylphenyl)dihydro-2,6(1H,3H)-pyridinedione C12H13NO2 详情 详情
(IV) 15514 1-[2-(bromomethyl)phenyl]dihydro-2,6(1H,3H)-pyridinedione C12H12BrNO2 详情 详情
(V) 15515 1-(2-[[bromo(triphenyl)phosphoranyl]methyl]phenyl)dihydro-2,6(1H,3H)-pyridinedione C30H27BrNO2P 详情 详情
(VI) 15516 8,9-dihydropyrido[1,2-a]indol-6(7H)-one C12H11NO 详情 详情
(VII) 15499 5-methyl-1-trityl-1H-imidazole-4-carbaldehyde C24H20N2O 详情 详情
(VIII) 15518 7-[hydroxy(5-methyl-1-trityl-1H-imidazol-4-yl)methyl]-8,9-dihydropyrido[1,2-a]indol-6(7H)-one C36H31N3O2 详情 详情
(IX) 15519 (5-methyl-1-trityl-1H-imidazol-4-yl)(6-oxo-6,7,8,9-tetrahydropyrido[1,2-a]indol-7-yl)methyl acetate C38H33N3O3 详情 详情
(X) 15520 7-[(E)-(1-benzyl-5-methyl-1H-imidazol-4-yl)methylidene]-8,9-dihydropyrido[1,2-a]indol-6(7H)-one C24H21N3O 详情 详情
(XI) 15521 7-[(E)-(5-methyl-1H-imidazol-4-yl)methylidene]-8,9-dihydropyrido[1,2-a]indol-6(7H)-one C17H15N3O 详情 详情
(XII) 15522 (rac)-(7-[(5-methyl-1H-imidazol-4-yl)methyl]-8,9-dihydropyrido[1,2-a]indol-6(7H)-one) C17H17N3O 详情 详情
(XIII) 64681 7-[(5-methyl-1H-imidazol-4-yl)methyl]-8,9-dihydropyrido[1,2-a]indol-6(7H)-one C17H17N3O 详情 详情
(XIV) 64682 10-[(dimethylamino)methyl]-7-[(5-methyl-1H-imidazol-4-yl)methyl]-8,9-dihydropyrido[1,2-a]indol-6(7H)-one C20H24N4O 详情 详情
(XV) 15524 (rac)-(10-[(dimethylamino)methyl]-7-[(5-methyl-1H-imidazol-4-yl)methyl]-8,9-dihydropyrido[1,2-a]indol-6(7H)-one) C20H24N4O 详情 详情
(XVI) 15526 10-methyl-7-[(5-methyl-1H-imidazol-4-yl)methyl]-8,9-dihydropyrido[1,2-a]indol-6(7H)-one C18H19N3O 详情 详情

合成路线2

该中间体在本合成路线中的序号:(II)

Friedel-Crafts condensation of 2-fluorobiphenyl (I) with glutaric anhydride (II) in the presence of AlCl3 gave ketoacid (III). Reduction of the ketonic group of (III) with triethylsilane in trifluoroacetic acid afforded biphenylpentanoic acid (IV), which was cyclized to the benzosuberone derivative (V) using polyphosphoric acid. Ketone reduction of (IV) by means of triethylsilane and trifluoroacetic acid provided the benzocycloheptene (VI), which was further oxidized to the isomeric ketone (VII) with chromic acid. Finally, condensation of (VII) with 5-fluoroisatin (VIII) in the presence of KOH yielded the target tetracyclic system.

1 Suzuki, F.; Nakasato, Y.; Tsumuki, H.; Ohmori, K.; Nakajima, H.; Tamura, T.; Sato, S. (Kyowa Hakko Kogyo Co., Ltd.); Tetracyclic cpds.. US 5371225; WO 9322286 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 31388 2-fluoro-1,1'-biphenyl 321-60-8 C12H9F 详情 详情
(II) 15512 Glutaric Anhydride; dihydro-2H-pyran-2,6(3H)-dione 108-55-4 C5H6O3 详情 详情
(III) 31389 5-(2'-fluoro[1,1'-biphenyl]-4-yl)-5-oxopentanoic acid C17H15FO3 详情 详情
(IV) 31390 5-(2'-fluoro[1,1'-biphenyl]-4-yl)pentanoic acid C17H17FO2 详情 详情
(V) 31391 3-(2-fluorophenyl)-6,7,8,9-tetrahydro-5H-benzo[a]cyclohepten-5-one C17H15FO 详情 详情
(VI) 31392 2-(2-fluorophenyl)-6,7,8,9-tetrahydro-5H-benzo[a]cycloheptene C17H17F 详情 详情
(VII) 31393 2-(2-fluorophenyl)-6,7,8,9-tetrahydro-5H-benzo[a]cyclohepten-5-one C17H15FO 详情 详情
(VIII) 21552 5-fluoro-1H-indole-2,3-dione 443-69-6 C8H4FNO2 详情 详情

合成路线3

该中间体在本合成路线中的序号:(I)

The title hemiglutarate ester was synthesized by acylation of the known olivacine derivative (I) with glutaric anhydride (II) in pyridine, followed by conversion to the corresponding dihydrochloride salt.

1 Charton, Y.; Guilbaud, N.; Léonce, S.; Pierré, A.; Guillonneau, C.; Michel, A.; Atassi, G.; Kraus-Berthier, L.; Bisagni, E.; Synthesis of 9-O-substituted derivatives of 9-hydroxy-5, 6-dimethyl-6H-pyrido[4,3-b]carbazole-1-carboxylic acid (2-(dimethylamino)ethyl)amide and their 10- and 11-methyl analogues with improved antitumor activity. J Med Chem 1999, 42, 12, 2191.
2 Guilbaud, N.; Bisagni, E.; Guillonneau, C.; Charton, Y.; Atassi, G.; Pierre, A. (ADIR et Cie.); Ellipticine derivs., their preparation and pharmaceutical compsns. containing them. EP 0850940; US 6162811 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 15512 Glutaric Anhydride; dihydro-2H-pyran-2,6(3H)-dione 108-55-4 C5H6O3 详情 详情
(II) 50481 N-[2-(dimethylamino)ethyl]-9-hydroxy-5,6-dimethyl-6H-pyrido[4,3-b]carbazole-1-carboxamide C22H24N4O2 详情 详情

合成路线4

该中间体在本合成路线中的序号:(V)

Condensation of the known chloro pyrazolopyridine (I) with the lithium salt of 4-chlorobenzylthiol (II) produces the intermediate thioether (III) which, in the presence of excess LDA, undergoes intramolecular Claisen condensation to the pyrazolothienopyridine derivative (IV). Subsequent acylation of (IV) with glutaric anhydride (V) in acetone gives rise to the target glutarate mono-ester.

1 da Silva, K.C.M.; Fraga, C.A.M.; Barreiro, E.J.; de Brito, F.C.F.; de Miranda, A.L.P.; Cardoso, C.R.; Design, synthesis and pharmacological evaluation of novel pyrazolo[3,4-b]thieno[2,3-d]pyridine acid derivatives: A new class of anti-inflammatory and anti-platelet agents. Bioorg Med Chem Lett 2002, 12, 1, 9.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 57506 ethyl 4-chloro-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylate C16H14ClN3O2 详情 详情
(II) 32674 (4-chlorophenyl)methanethiol; 4-chlorobenzylhydrosulfide 6258-66-8 C7H7ClS 详情 详情
(III) 52507 6-chloro-2-nitro-9-oxo-9,10-dihydro-4-acridinecarboxylic acid C14H7ClN2O5 详情 详情
(IV) 57508 2-(4-chlorophenyl)-8-methyl-6-phenyl-6H-pyrazolo[3,4-b]thieno[2,3-d]pyridin-3-ol C21H14ClN3OS 详情 详情
(V) 15512 Glutaric Anhydride; dihydro-2H-pyran-2,6(3H)-dione 108-55-4 C5H6O3 详情 详情

合成路线5

该中间体在本合成路线中的序号:(XXVI)

Acylation of 9-fluorenylmethanol (XXV) with glutaric anhydride (XXVI) yielded the glutarate mono-ester (XV). This was further activated as the pentafluorophenyl ester (XXVII) upon treatment with pentafluorophenol and DCC. Coupling of active ester (XXVII) with tripeptide (XXIV) gave rise to the glutaryl tripeptide (XXVIII).

1 Kaufman, M.J.; Almarsson, O.; Nerurkar, M.J.; Lynch, J.E.; Karki, S.B.; Cameron, M.; Lieberman, D.R.; Robbins, M.A.; Shi, Y.-J. (Merck & Co., Inc.); Salt form of a conjugate useful in the treatment of prostate cancer. US 6355611; WO 0130804 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XV) 53680 5-(9H-fluoren-9-ylmethoxy)-5-oxopentanoic acid n/a C19H18O4 详情 详情
(XXIV) 53678 (2S)-3-hydroxy-2-{[(2S)-2-({[(2S,4R)-4-hydroxypyrrolidinyl]carbonyl}amino)propanoyl]amino}propanoic acid n/a C11H19N3O6 详情 详情
(XXV) 53679 9H-fluoren-9-ylmethanol 24324-17-2 C14H12O 详情 详情
(XXVI) 15512 Glutaric Anhydride; dihydro-2H-pyran-2,6(3H)-dione 108-55-4 C5H6O3 详情 详情
(XXVII) 53681 1-(9H-fluoren-9-ylmethyl) 5-(2,3,4,5,6-pentafluorophenyl) pentanedioate n/a C25H17F5O4 详情 详情
(XXVIII) 53682 (2S)-2-({(2S)-2-[({(2S,4R)-1-[5-(9H-fluoren-9-ylmethoxy)-5-oxopentanoyl]-4-hydroxypyrrolidinyl}carbonyl)amino]propanoyl}amino)-3-hydroxypropanoic acid n/a C30H35N3O9 详情 详情

合成路线6

该中间体在本合成路线中的序号:(V)

Coupling of AZT (I) with Boc-Gly-OH (II) by means of dicyclohexyl carbodiimide (DCC) in the presence of dimethylaminopyridine (DMAP) in DMF followed by Boc removal by treatment with HCl/dioxane yields AZT ester (III). On the other hand, KNI-727 (IV) is condensed with glutaric anhydride (V) in THF-ether in the presence of dicyclohexylamine (DCHA) to yield the half ester of KNI-727 (VI), which is then condensed with derivative (III) by means of EDC.HCl in DMF in the presence of HOBt to furnish the target compound.

1 Sano, K.; Kimura, T.; Hamawaki, T.; Matsumoto, H.; Ota, H.; Hayashi, Y.; Kiso, Y.; Goto, T.; "Double-drugs" - a new class of prodrug form of an HIV protease inhibitor conjugated with a reverse transcriptase inhibitor by a spontaneously cleavable linker. Bioorg Med Chem Lett 2000, 10, 11, 1227.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 45465 1-[(4S,5S)-4-azido-5-(hydroxymethyl)isoxazolidinyl]-5-methyl-2,4(1H,3H)-pyrimidinedione C9H12N6O4 详情 详情
(II) 18066 N-alpha-t-BOC-glycine; 2-[(tert-butoxycarbonyl)amino]acetic acid 4530-20-5 C7H13NO4 详情 详情
(III) 45466 [(4S,5S)-4-azido-2-[5-methyl-2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl]isoxazolidinyl]methyl 2-aminoacetate C11H15N7O5 详情 详情
(IV) 45467 (4R)-N-(tert-butyl)-3-((2S,3S)-3-[[2-(2,6-dimethylphenoxy)acetyl]amino]-2-hydroxy-4-phenylbutanoyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide C30H41N3O5S 详情 详情
(V) 15512 Glutaric Anhydride; dihydro-2H-pyran-2,6(3H)-dione 108-55-4 C5H6O3 详情 详情
(VI) 45468 5-[((1S,2S)-1-([(4R)-4-[(tert-butylamino)carbonyl]-5,5-dimethyl-1,3-thiazolidin-3-yl]carbonyl)-2-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-phenylpropyl)oxy]-5-oxopentanoic acid C35H47N3O8S 详情 详情

合成路线7

该中间体在本合成路线中的序号:(III)

The reaction of triamcinolone (I) with acetone and HCl gives the corresponding acetonide (II), which is condensed with glutaric anhydride (III) in pyridine to yield the glutaric monoester (IV). Finally, this compound is condensed with mitomycin C (V) by means of CDI in THF to afford the target conjugate.

1 Crosson, C.E.; Künzel, E.; Heredia, M.L.; Rix, U.; Oelkers, C.; Rohr, J.; Rohrer, B.; Winberly, M.; Macky, T.A.; Synthesis, pharmacokinetics, efficacy, and rat retinal toxicity of a novel mitomycin C-triamcinolone acetonide conjugate. J Med Chem 2002, 45, 5, 1122.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 39959 (8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-17-glycoloyl-11,16,17-trihydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one 124-94-7 C21H27FO6 详情 详情
(II) 53587 5-{2-[(4aS,4bR,5S,6aS,9aR,10aS,10bS)-4b-fluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6-yl]-2-oxoethoxy}-5-oxopentanoic acid n/a C29H37FO9 详情 详情
(III) 15512 Glutaric Anhydride; dihydro-2H-pyran-2,6(3H)-dione 108-55-4 C5H6O3 详情 详情
(IV) 53588 [(1aS,8S,8aR,8bS)-6-amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazireno[2',3':3,4]pyrrolo[1,2-a]indol-8-yl]methyl carbamate n/a C15H18N4O5 详情 详情
(V) 53589 2-Nitro-p-phenetidine; 4-Amino-3-nitrophenetole; 4-Ethoxy-2-nitroaniline; 4-Ethoxy-2-nitrobenzeneamine 616-86-4 C8H10N2O3 详情 详情

合成路线8

该中间体在本合成路线中的序号:(IV)

1 Gao LM, Wang YX, Song DQ. 2007. Synthesis of 5-[bis (2-choloethyl) amino] -1-methyl-1H-benzimidazole-2-butanoic acid hydrochloride (bendamustine hydrochloride). 中国新药杂志, 16(23): 1960~1961, 1970.
2 Krueger W, Krueger G. 1983. 4-[1-methyl-5-bis[(2-chloroethyl) amino] -2-benzimidazolyl] butyric acid. Ger, (East)DD 159877. Krueger W, Krueger G. 1983. 4-[1-methyl-5-bis[(2-chloroethyl) amino] -2-benzimidazolyl] butyric acid. Ger, (East)DD 159877. Krueger W, Krueger G. 1983. 4-[1-methyl-5-bis[(2-chloroethyl) amino] -2-benzimidazolyl] butyric acid. Ger, (East)DD 159877. Krueger W, Krueger G. 1983. 4-[1-methyl-5-bis[(2-chloroethyl) amino] -2-benzimidazolyl] butyric acid. Ger, (East)DD 159877. Krueger W, Krueger G. 1983. 4-[1-methyl-5-bis[(2-chloroethyl) amino] -2-benzimidazolyl] butyric acid. Ger, (East)DD 159877. Krueger W, Krueger G. 1983. 4-[1-methyl-5-bis[(2-chloroethyl) amino] -2-benzimidazolyl] butyric acid. Ger, (East)DD 159877.
3 Werner W, Letsch G, Ihn W. 1987. Hydrolysis products of the antitumor drug cytostasan(bendamustin). Pharmazic, 42(4): 272~273. Krueger W, Krueger G. 1983. 4-[1-methyl-5-bis[(2-chloroethyl) amino] -2-benzimidazolyl] butyric acid. Ger, (East)DD 159877.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 10378 1-Chloro-2,4-dinitrobenzene 97-00-7 C6H3ClN2O4 详情 详情
(II) 67047 N-methyl-2,4-dinitroaniline 2044-88-4 C7H7N3O4 详情 详情
(III) 67048 N1-methyl-4-nitrobenzene-1,2-diamine 41939-61-1 C7H9N3O2 详情 详情
(IV) 15512 Glutaric Anhydride; dihydro-2H-pyran-2,6(3H)-dione 108-55-4 C5H6O3 详情 详情
(V) 67049 5-((2-(methylamino)-5-nitrophenyl)amino)-5-oxopentanoic acid   C12H15N3O5 详情 详情
(VI) 67050 ethyl 4-(1-methyl-5-nitro-1H-benzo[d]imidazol-2-yl)butanoate 3543-72-4 C14H17N3O4 详情 详情
(VII) 67051 ethyl 4-(5-amino-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate 3543-73-5 C14H19N3O2 详情 详情
(VIII) 10393 Oxirane; Ethylene oxide 75-21-8 C2H4O 详情 详情
(IX) 67052 ethyl 4-(5-(bis(2-hydroxyethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate 3543-74-6 C18H27N3O4 详情 详情
Extended Information